Skip to main content
141dcc82d7e2b781f26a993926c0926644def76d.jpeg.jpg

Bernie Sanders Takes Aim at Wealth—and Warren

Bernie’s new corporate accountability plan heightens the contrast between his brand of socialism and his progressive rival’s institutionalism. As radical as Sanders’s plan substantively is, survey data on worker ownership suggests that the public may well be receptive to proposals that go even further. A YouGov poll commissioned by worker-ownership advocacy group Democracy Collaborative earlier this year found that 55 percent of Americans would support requiring companies with at least 250 employees to eventually transfer as much as 50 percent of their stock to workers. 

Publication date: 2019-10-14
Parent publication: New Republic
Publication URL: https://newrepublic.com/article/155360/bernie-sanders-takes-aim-wealthand-warren

More related work

March 19, 2020
Default Image

Protect the vulnerable, advance the democratic economy: Our statement on the COVID-19 crisis

We are in a period of breakdown, in which all that is wrong with the current system is now being laid bare. Rather than rebuild what we now clearly see should never have been, we must lead the construction out of this crisis of something new.

read more
March 18, 2020
Default Image

HAN Public Comments on Fair Housing Act Proposed Changes

The Healthcare Anchor Network submitted public comments to the Department of Housing and Urban Development (HUD), expressing our opposition to HUD’s proposed changes to the 2015 Affirmatively Furthering Fair Housing rule.

read more
March 17, 2020
An array of prescription medications on shelves

Online press briefing: Vaccines—The COVID-19 Case for Public Pharmaceutical Research and Development

Leading experts believe that it is the government’s responsibility to ensure widespread access to safe and effective vaccines that are developed with taxpayer money. In this virtual press briefing, hear why the U.S. government should develop and manufacture vaccines and other essential medicines so that we get the medicines we need, when we need them and at prices we can afford.

read more